mifepristone has been researched along with nicotine in 16 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (12.50) | 18.2507 |
| 2000's | 6 (37.50) | 29.6817 |
| 2010's | 7 (43.75) | 24.3611 |
| 2020's | 1 (6.25) | 2.80 |
| Authors | Studies |
|---|---|
| Dansette, PM; Fontana, E; Poli, SM | 1 |
| Artursson, P; Bergström, CA; Hoogstraate, J; Matsson, P; Norinder, U; Pedersen, JM | 1 |
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Artursson, P; Haglund, U; Karlgren, M; Kimoto, E; Lai, Y; Norinder, U; Vildhede, A; Wisniewski, JR | 1 |
| Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
| Betito, K; Boksa, P; Diorio, J | 1 |
| Benowitz, NL; Heller, PH; Levine, JD; Miao, FJ | 1 |
| Kita, T; Kubo, K; Nakashima, T; Nakatani, T; Narushima, I; Tanaka, T | 1 |
| Harris, BR; Littleton, JM; Mulholland, PJ; Prendergast, MA; Self, RL | 1 |
| Fagen, ZM; McGehee, DS; Mitchum, R; Vezina, P | 1 |
| Radcliffe, PM; Sterling, CR; Tank, AW | 1 |
| Pogun, S; Yararbas, G | 1 |
| Diana, M; Enrico, P; Mercante, B; Mereu, M; Peana, AT; Sirca, D | 1 |
| Dani, JA; Dong, Y; Doyon, WM; Ostroumov, A; Thomas, AM; Zhang, TA | 1 |
| El-Demellawy, MA; El-Gowelli, HM; El-gowilly, SM; El-Mas, MM; Gohar, EY | 1 |
| Bao, J; Garfield, RE; Huang, Q; Li, P; Liu, H; Ye, A | 1 |
1 review(s) available for mifepristone and nicotine
| Article | Year |
|---|---|
Cytochrome p450 enzymes mechanism based inhibitors: common sub-structures and reactivity.
Topics: Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Drug Interactions; Enzyme Inhibitors; Humans; Isoenzymes; Structure-Activity Relationship; Terminology as Topic | 2005 |
15 other study(ies) available for mifepristone and nicotine
| Article | Year |
|---|---|
Prediction and identification of drug interactions with the human ATP-binding cassette transporter multidrug-resistance associated protein 2 (MRP2; ABCC2).
Topics: Administration, Oral; Animals; Antineoplastic Agents; Antipsychotic Agents; Antiviral Agents; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 1; ATP Binding Cassette Transporter, Subfamily G, Member 2; ATP-Binding Cassette Transporters; Biological Transport; Cell Line; Computer Simulation; Cytochrome P-450 Enzyme System; Drug-Related Side Effects and Adverse Reactions; Estradiol; Humans; Insecta; Liver; Models, Molecular; Multidrug Resistance-Associated Protein 2; Multidrug Resistance-Associated Proteins; Neoplasm Proteins; Pharmaceutical Preparations; Pharmacology; Structure-Activity Relationship | 2008 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Classification of inhibitors of hepatic organic anion transporting polypeptides (OATPs): influence of protein expression on drug-drug interactions.
Topics: Atorvastatin; Biological Transport; Drug Interactions; Estradiol; Estrone; HEK293 Cells; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; In Vitro Techniques; Least-Squares Analysis; Liver; Liver-Specific Organic Anion Transporter 1; Models, Molecular; Multivariate Analysis; Organic Anion Transporters; Organic Anion Transporters, Sodium-Independent; Protein Isoforms; Pyrroles; Solute Carrier Organic Anion Transporter Family Member 1B3; Structure-Activity Relationship; Transfection | 2012 |
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |
Brief cortisol exposure elevates adrenal phenylethanolamine N-methyltransferase after a necessary lag period.
Topics: Adrenal Medulla; Animals; Cattle; Cells, Cultured; Dose-Response Relationship, Drug; Drug Interactions; Drug Synergism; Hydrocortisone; Mifepristone; Nicotine; Phenylethanolamine N-Methyltransferase | 1993 |
Contribution of adrenal hormones to nicotine-induced inhibition of synovial plasma extravasation in the rat.
Topics: Adrenal Glands; Animals; Bradykinin; Capillary Permeability; Male; Mecamylamine; Mifepristone; Naloxone; Nicotine; Platelet Activating Factor; Propanolamines; Rats; Rats, Sprague-Dawley | 1997 |
Nicotine-induced inflammatory decreasing effect on passive skin arthus reaction in paraventricular nucleus-lesioned wistar rats.
Topics: Animals; Arthus Reaction; Corticosterone; Cycloheximide; Dose-Response Relationship, Drug; Hexamethonium; Injections, Intraperitoneal; Injections, Subcutaneous; Male; Mecamylamine; Mifepristone; Nicotine; Nicotinic Agonists; Nicotinic Antagonists; Paraventricular Hypothalamic Nucleus; Rabbits; Rats; Rats, Wistar; Skin; Time Factors | 2003 |
(-)-nicotine ameliorates corticosterone's potentiation of N-methyl-d-aspartate receptor-mediated cornu ammonis 1 toxicity.
Topics: Aconitine; alpha7 Nicotinic Acetylcholine Receptor; Animals; Cell Survival; Corticosterone; Disease Models, Animal; Drug Interactions; Hippocampus; In Vitro Techniques; Male; Mifepristone; N-Methylaspartate; Neurons; Neuroprotective Agents; Neurotoxins; Nicotine; Nicotinic Antagonists; Rats; Rats, Sprague-Dawley; Receptors, Glucocorticoid; Receptors, N-Methyl-D-Aspartate; Receptors, Nicotinic | 2004 |
Enhanced nicotinic receptor function and drug abuse vulnerability.
Topics: Animals; Behavior, Animal; Bicuculline; Cells, Cultured; Corticosterone; Dopamine; Electric Stimulation; Hormone Antagonists; In Vitro Techniques; Male; Membrane Potentials; Mifepristone; Motor Activity; Neurons; Nicotine; Nicotinic Agonists; Patch-Clamp Techniques; Rats; Rats, Sprague-Dawley; Receptors, Nicotinic; Statistics as Topic; Stress, Physiological; Ventral Tegmental Area | 2007 |
Induction of tyrosine hydroxylase mRNA by nicotine in rat midbrain is inhibited by mifepristone.
Topics: Animals; Animals, Newborn; Cell Line, Tumor; Dexamethasone; Dose-Response Relationship, Drug; Gene Expression Regulation, Enzymologic; Glucocorticoids; Hormone Antagonists; In Vitro Techniques; Male; Mesencephalon; Mice; Mifepristone; Neuroblastoma; Nicotine; Nicotinic Agonists; Rats; Rats, Sprague-Dawley; RNA, Messenger; Time Factors; Tyrosine 3-Monooxygenase | 2009 |
Tamoxifen and mifepriston modulate nicotine induced conditioned place preference in female rats.
Topics: Animals; Conditioning, Psychological; Female; Hormone Antagonists; Humans; Male; Mifepristone; Nicotine; Nicotinic Agonists; Rats; Rats, Sprague-Dawley; Selective Estrogen Receptor Modulators; Smoking Cessation; Tamoxifen; Tobacco Use Disorder | 2011 |
Acute restraint stress prevents nicotine-induced mesolimbic dopaminergic activation via a corticosterone-mediated mechanism: a microdialysis study in the rat.
Topics: Animals; Corticosterone; Dopamine; Limbic System; Male; Microdialysis; Mifepristone; Nicotine; Random Allocation; Rats; Rats, Wistar; Restraint, Physical; Stress, Psychological | 2013 |
Nicotine decreases ethanol-induced dopamine signaling and increases self-administration via stress hormones.
Topics: Animals; Animals, Newborn; Central Nervous System Depressants; Conditioning, Operant; Dopamine; Drug Interactions; Ethanol; GABA Antagonists; Hormone Antagonists; Hormones; In Vitro Techniques; Mifepristone; Nicotine; Nicotinic Agonists; Nicotinic Antagonists; Rats; Rats, Long-Evans; Receptors, Nicotinic; Self Administration; Signal Transduction; Time Factors; Tyrosine 3-Monooxygenase; Ventral Tegmental Area | 2013 |
PI3K/Akt-independent NOS/HO activation accounts for the facilitatory effect of nicotine on acetylcholine renal vasodilations: modulation by ovarian hormones.
Topics: Acetylcholine; Adenosine-5'-(N-ethylcarboxamide); Animals; Area Under Curve; Arginine; Enzyme Activation; Estradiol; Female; Heme Oxygenase (Decyclizing); Hemin; Hormones; In Vitro Techniques; Kidney; Medroxyprogesterone Acetate; Mifepristone; Nicotine; Nitric Oxide Synthase; Papaverine; Phenylephrine; Phosphatidylinositol 3-Kinases; Proto-Oncogene Proteins c-akt; Rats, Wistar; Signal Transduction; Vasodilation | 2014 |
Nicotine ameliorates inflammatory mediators in RU486 induced preterm labor model through activating cholinergic anti-inflammatory pathway.
Topics: alpha7 Nicotinic Acetylcholine Receptor; Animals; Anti-Inflammatory Agents; Cytokines; Female; Inflammation; Inflammation Mediators; Interleukin-10; Interleukin-4; Interleukin-6; Mifepristone; Neuroimmunomodulation; Nicotine; Obstetric Labor, Premature; Pregnancy; Premature Birth; Rats; Tumor Necrosis Factor-alpha | 2022 |